These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 35792236)

  • 21. Combination of modified carbapenem inactivation method (mCIM) and EDTA-CIM (eCIM) for phenotypic detection of carbapenemase-producing Enterobacteriaceae.
    Tsai YM; Wang S; Chiu HC; Kao CY; Wen LL
    BMC Microbiol; 2020 Oct; 20(1):315. PubMed ID: 33069233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular characteristics of carbapenem-resistant Acinetobacter spp. from clinical infection samples and fecal survey samples in Southern China.
    Li S; Duan X; Peng Y; Rui Y
    BMC Infect Dis; 2019 Oct; 19(1):900. PubMed ID: 31660862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Molecular and Phenotypic Methods for the Detection and Characterization of Carbapenem Resistant Enterobacteriaceae.
    Somily AM; Garaween GA; Abukhalid N; Absar MM; Senok AC
    Acta Microbiol Immunol Hung; 2016 Mar; 63(1):69-81. PubMed ID: 27020870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of specific inhibitors on metallo-β-carbapenemases detected in Escherichia coli and Klebsiella pneumoniae isolates.
    Abbas HA; Kadry AA; Shaker GH; Goda RM
    Microb Pathog; 2019 Jul; 132():266-274. PubMed ID: 31096002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Statewide surveillance of carbapenemase-producing carbapenem-resistant
    Precit MR; Kauber K; Glover WA; Weissman SJ; Robinson T; Tran M; D'Angeli M
    Infect Control Hosp Epidemiol; 2020 Jun; 41(6):716-722. PubMed ID: 32192546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Carbapenem resistance in ESBL positive Enterobacteriaceae isolates causing invasive infections].
    Eser OK; Altun Uludağ H; Ergin A; Boral B; Sener B; Hasçelik G
    Mikrobiyol Bul; 2014 Jan; 48(1):59-69. PubMed ID: 24506716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emergence of carbapenemase-producing and colistin resistant Klebsiella pneumoniae ST101 high-risk clone in Turkey.
    Hazırolan G; Karagöz A
    Acta Microbiol Immunol Hung; 2020 Nov; 67(4):216-221. PubMed ID: 33174866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insights on the performance of phenotypic tests versus genotypic tests for the detection of carbapenemase-producing Gram-negative bacilli in resource-limited settings.
    Kamel NA; Tohamy ST; Yahia IS; Aboshanab KM
    BMC Microbiol; 2022 Oct; 22(1):248. PubMed ID: 36229768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular epidemiology & therapeutic options of carbapenem-resistant Gram-negative bacteria.
    Garg A; Garg J; Kumar S; Bhattacharya A; Agarwal S; Upadhyay GC
    Indian J Med Res; 2019 Feb; 149(2):285-289. PubMed ID: 31219096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of Carbapenem-Resistant Genes in
    Mahmoud NE; Altayb HN; Gurashi RM
    J Environ Public Health; 2020; 2020():2571293. PubMed ID: 32612664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of blaKPC and blaNDM carbapenemase genes among Klebsiella pneumoniae isolates in Addis Ababa, Ethiopia: Dominance of blaNDM.
    Awoke T; Teka B; Aseffa A; Sebre S; Seman A; Yeshitela B; Abebe T; Mihret A
    PLoS One; 2022; 17(4):e0267657. PubMed ID: 35476721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of carbapenemase and mcr-1 genes in carbapenem-resistant Klebsiella pneumoniae isolates.
    Arabacı Ç; Dal T; Başyiğit T; Genişel N; Durmaz R
    J Infect Dev Ctries; 2019 Jun; 13(6):504-509. PubMed ID: 32058985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid detection of carbapenemase-producing gram-negative bacteria directly from blood culture bottles for a reliable guided empiric therapy.
    Rezk S; Ashraf N; Heshmat H; Elsawaf G; Elsheredy A
    Acta Microbiol Immunol Hung; 2024 Jul; 71(2):140-147. PubMed ID: 38573768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Occurrence and Characterization of Carbapenemase-Producing Enterobacteriaceae in a Tunisian Hospital.
    Ben Helal R; Dziri R; Chedly M; Klibi N; Barguellil F; El Asli MS; Ben Moussa M
    Microb Drug Resist; 2018 Nov; 24(9):1361-1367. PubMed ID: 29596032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in ICU of the eastern Heilongjiang Province, China.
    Zhao Y; Hu K; Zhang J; Guo Y; Fan X; Wang Y; Mensah SD; Zhang X
    BMC Infect Dis; 2019 May; 19(1):452. PubMed ID: 31113374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An agar plate-based modified carbapenem inactivation method (p-mCIM) for detection of carbapenemase-producing Enterobacteriaceae.
    Byun JH; Seo Y; Kim D; Kim M; Lee H; Yong D; Lee K; Chong Y
    J Microbiol Methods; 2020 Jan; 168():105781. PubMed ID: 31756348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of sCIM and Other Phenotypic Detection Methods for Carbapenemase-Producing
    Hosoda T; Doi Y; Suzuki M
    Microbiol Spectr; 2021 Dec; 9(3):e0160821. PubMed ID: 34787440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. mCIM test as a reliable assay for the detection of CRE in the Gulf region.
    Al Musawi S; Ur Rahman J; Aljaroodi SA; AlShammari L; Itbaileh A; Mohammed H; Saeed N; Abdalhamid B; Alkharsah KR; Aljindan RY
    J Med Microbiol; 2021 Jul; 70(7):. PubMed ID: 34232118
    [No Abstract]   [Full Text] [Related]  

  • 39. VIM-1, VIM-2, and GES-5 Carbapenemases Among Pseudomonas aeruginosa Isolates at a Tertiary Hospital in Istanbul, Turkey.
    Malkoçoğlu G; Aktaş E; Bayraktar B; Otlu B; Bulut ME
    Microb Drug Resist; 2017 Apr; 23(3):328-334. PubMed ID: 27326514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug resistance phenotypes and genotypes in Mexico in representative gram-negative species: Results from the infivar network.
    Garza-González E; Bocanegra-Ibarias P; Bobadilla-Del-Valle M; Ponce-de-León-Garduño LA; Esteban-Kenel V; Silva-Sánchez J; Garza-Ramos U; Barrios-Camacho H; López-Jácome LE; Colin-Castro CA; Franco-Cendejas R; Flores-Treviño S; Morfín-Otero R; Rojas-Larios F; Mena-Ramírez JP; Fong-Camargo MG; Morales-De-la-Peña CT; García-Mendoza L; Choy-Chang EV; Aviles-Benitez LK; Feliciano-Guzmán JM; López-Gutiérrez E; Gil-Veloz M; Barajas-Magallón JM; Aguirre-Burciaga E; López-Moreno LI; Martínez-Villarreal RT; Canizales-Oviedo JL; Cetina-Umaña CM; Romero-Romero D; Bello-Pazos FD; Barlandas-Rendón NRE; Maldonado-Anicacio JY; Bolado-Martínez E; Galindo-Méndez M; Perez-Vicelis T; Alavez-Ramírez N; Méndez-Sotelo BJ; Cabriales-Zavala JF; Nava-Pacheco YC; Moreno-Méndez MI; García-Romo R; Silva-Gamiño AR; Avalos-Aguilera AM; Santiago-Calderón MA; López-García M; Velázquez-Acosta MDC; Cobos-Canul DI; Vázquez-Larios MDR; Ortiz-Porcayo AE; Guerrero-Núñez AE; Valero-Guzmán J; Rosales-García AA; Ostos-Cantú HL; Camacho-Ortiz A
    PLoS One; 2021; 16(3):e0248614. PubMed ID: 33730101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.